Showing results (1-10 of 434) with videos related to
Sort By:
Pageof 44
NPJ Genomic Medicine|March 21, 2020
Emerging strategies to bridge the gap between pharmacogenomic research and its clinical implementationVolker M Lauschke, Magnus Ingelman-SundbergEuropean Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 27, 2019
Prediction of drug response and adverse drug reactions: From twin studies to Next Generation SequencingVolker M Lauschke, Magnus Ingelman-SundbergTrends in Pharmacological Sciences|June 24, 2020
Can CYP Inhibition Overcome Chemotherapy Resistance?Magnus Ingelman-Sundberg, Volker M LauschkeClinical Pharmacology and Therapeutics|January 10, 2018
How to Consider Rare Genetic Variants in Personalized Drug TherapyVolker M Lauschke, Magnus Ingelman-SundbergBasic & Clinical Pharmacology & Toxicology|April 19, 2021
3D human liver spheroids for translational pharmacology and toxicologyMagnus Ingelman-Sundberg, Volker M LauschkePharmacogenomics|June 2, 2016
Requirements for comprehensive pharmacogenetic genotyping platformsVolker M Lauschke, Magnus Ingelman-SundbergInternational Journal of Molecular Sciences|October 19, 2016
The Importance of Patient-Specific Factors for Hepatic Drug Response and ToxicityVolker M Lauschke, Magnus Ingelman-SundbergPharmacological Reviews|March 10, 2026
The evolving landscape of pharmacogenomics: Current achievements and future directionsVolker M Lauschke, Magnus Ingelman-SundbergPharmacogenomics|July 26, 2018
Human liver spheroids in chemically defined conditions for studies of gene-drug, drug-drug and disease-drug interactionsMagnus Ingelman-Sundberg, Volker M LauschkeDrug Metabolism and Disposition: the Biological Fate of Chemicals|April 4, 2024
Individualized Pharmacotherapy Utilizing Genetic Biomarkers and Novel In Vitro Systems As Predictive Tools for Optimal Drug Development and TreatmentMagnus Ingelman-Sundberg, Volker M LauschkePageof 44